Skip to content

Investigating the Effect of Pregabalin in Burn Patients

Investigating the Effect of Pregabalin on the Intensity of Pain, Itching and Sleep Quality of Burn Patients

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20241025063491N1
Enrollment
60
Registered
2024-11-04
Start date
2024-10-27
Completion date
Unknown
Last updated
2025-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Burning.

Interventions

Intervention group: After the burn recovery process, the patients will be divided into 2 control and control groups. Then, the intervention group will be given pregabalin twice a day with a dose of 7

Sponsors

Yasouj University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 50 Years

Inclusion criteria

Inclusion criteria: The Extent of Burns is 10 to 35% Getting 2nd and 3rd Degree Burns Being in the Age Range of 20 to 50 Years Absence of Head, Face, Neck Burns and Inhalation Burns No History of Sleep Disorders Not Having a History of Mental Illness Use of Neuroleptics

Exclusion criteria

Exclusion criteria: Announcing withdrawal from the Study Occurrence of Drug Side Effects

Design outcomes

Primary

MeasureTime frame
Sleep quality disorders. Timepoint: On the seventh day after the start of the study and the CMP day from the start of the study. Method of measurement: Pittsburgh Questionnaire.

Secondary

MeasureTime frame
Pain?Itching. Timepoint: On the seventh day after the start of the study and the CMP day from the start of the study. Method of measurement: Visual analoge scale.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactTahereh taghvaee

Yasouj University of Medical Sciences

T.taghvaee77@gmail.com+98 74 3333 7001

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026